These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 15905549)
1. Reduction of spontaneous metastases through induction of carbohydrate cross-reactive apoptotic antibodies. Monzavi-Karbassi B; Artaud C; Jousheghany F; Hennings L; Carcel-Trullols J; Shaaf S; Korourian S; Kieber-Emmons T J Immunol; 2005 Jun; 174(11):7057-65. PubMed ID: 15905549 [TBL] [Abstract][Full Text] [Related]
2. Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo. Allen SD; Garrett JT; Rawale SV; Jones AL; Phillips G; Forni G; Morris JC; Oshima RG; Kaumaya PT J Immunol; 2007 Jul; 179(1):472-82. PubMed ID: 17579068 [TBL] [Abstract][Full Text] [Related]
3. Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro. Wagner S; Hafner C; Allwardt D; Jasinska J; Ferrone S; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H; Breiteneder H J Immunol; 2005 Jan; 174(2):976-82. PubMed ID: 15634921 [TBL] [Abstract][Full Text] [Related]
4. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. Monzavi-Karbassi B; Pashov A; Jousheghany F; Artaud C; Kieber-Emmons T Int J Mol Med; 2006 Jun; 17(6):1045-52. PubMed ID: 16685414 [TBL] [Abstract][Full Text] [Related]
5. Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response. Kieber-Emmons T; Monzavi-Karbassi B; Wang B; Luo P; Weiner DB J Immunol; 2000 Jul; 165(2):623-7. PubMed ID: 10878332 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Kieber-Emmons T; Luo P; Qiu J; Chang TY; O I; Blaszczyk-Thurin M; Steplewski Z Nat Biotechnol; 1999 Jul; 17(7):660-5. PubMed ID: 10404158 [TBL] [Abstract][Full Text] [Related]
7. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines. Qiu J; Luo P; Wasmund K; Steplewski Z; Kieber-Emmons T Hybridoma; 1999 Feb; 18(1):103-12. PubMed ID: 10211797 [TBL] [Abstract][Full Text] [Related]
9. Lectin-induced apoptosis of tumour cells. Kim M; Rao MV; Tweardy DJ; Prakash M; Galili U; Gorelik E Glycobiology; 1993 Oct; 3(5):447-53. PubMed ID: 8286857 [TBL] [Abstract][Full Text] [Related]
10. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor. Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014 [TBL] [Abstract][Full Text] [Related]
11. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568 [TBL] [Abstract][Full Text] [Related]
14. Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases. Lewis JD; Shearer MH; Kennedy RC; Bright RK Cancer Res; 2005 Apr; 65(7):2938-46. PubMed ID: 15805297 [TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Hubert P; Heitzmann A; Viel S; Nicolas A; Sastre-Garau X; Oppezzo P; Pritsch O; Osinaga E; Amigorena S Cancer Res; 2011 Aug; 71(15):5134-43. PubMed ID: 21697279 [TBL] [Abstract][Full Text] [Related]
16. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases. Yu P; Lee Y; Wang Y; Liu X; Auh S; Gajewski TF; Schreiber H; You Z; Kaynor C; Wang X; Fu YX J Immunol; 2007 Aug; 179(3):1960-8. PubMed ID: 17641063 [TBL] [Abstract][Full Text] [Related]
17. Use of surrogate antigens as vaccines against cancer. Monzavi-Karbassi B; Cunto-Amesty G; Luo P; Kieber-Emmons T Hybrid Hybridomics; 2002 Apr; 21(2):103-9. PubMed ID: 12031099 [TBL] [Abstract][Full Text] [Related]
18. A novel recombinant anti-epidermal growth factor receptor peptide vaccine capable of active immunization and reduction of tumor volume in a mouse model. Asadi-Ghalehni M; Rasaee MJ; RajabiBazl M; Khosravani M; Motaghinejad M; Javanmardi M; Khalili S; Modjtahedi H; Sadroddiny E Microbiol Immunol; 2017 Dec; 61(12):531-538. PubMed ID: 29023946 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies. Porzia A; Lanzardo S; Citti A; Cavallo F; Forni G; Santoni A; Galandrini R; Paolini R J Immunol; 2010 Apr; 184(8):4170-7. PubMed ID: 20220087 [TBL] [Abstract][Full Text] [Related]
20. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs. Chen CH; Ji H; Suh KW; Choti MA; Pardoll DM; Wu TC Gene Ther; 1999 Dec; 6(12):1972-81. PubMed ID: 10637448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]